However, at the time of clinical diagnosis of liver cancer, the staging of AFP-negative HCC was tantamount to that in AFP-positive HCC patients, which may be related to the lack of extensive use of a highly sensitive screening index. This evidence concerns the gene AFP and hepatocellular carcinoma.